Fate Therapeutics FATE
NASDAQ FATE
$1.61 -0.16 (-9.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Fate Therapeutics (FATE) Long-Term Debt Issuances (2013 - 2014)

Updated

Fate Therapeutics' Long-Term Debt Issuances came in at $15 million for FY2017, up 50.0% from $10 million in FY2016.

Analysis

Fate Therapeutics (FATE) Long-Term Debt Issuances (2013 - 2014) Analysis & Trends

Going back to FY2011, Fate Therapeutics' Long-Term Debt Issuances data covers 6 years.

  • Long-Term Debt Issuances carries a four-year compound annual growth rate of -10.8% (FY2013 to FY2017).
  • The FY2017 figure represents the highest annual Long-Term Debt Issuances since FY2014.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $10 million in FY2016 (unchanged), $10 million in FY2015 (-50.0%), $20 million in FY2014 (-15.7%) and $23.74 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Fate Therapeutics 215.18 Mn 76.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 10.00 Mn
Mar 31, 2014 6.40 Mn
Sep 30, 2013 20.74 Mn
API Access

Fate Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=FATE&period=max&api_key=YOUR_API_KEY